http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10111934-B2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2e3830f35387a1c32061dea3ee310851 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-30 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-30 |
| filingDate | 2014-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2018-10-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a7ce00ed597301e8ef503496397b9221 |
| publicationDate | 2018-10-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-10111934-B2 |
| titleOfInvention | IGF-1 proteins and therapeutic uses thereof |
| abstract | The present disclosure provides for techniques using pro-IGF-I for increasing IGF-I activity. Accordingly, the present disclosure provides for compositions and methods for treating or preventing a disease or disorder mediated by IGF-I. In addition, the present disclosure provides for kits for use in the treatment or prevention of a disease or disorder mediated by IGF-I. |
| priorityDate | 2012-07-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 779.